BRIGHT Run Breast Cancer Learning Health System Chair – applications being accepted until 8-15-2020

The McMaster Department of Oncology is seeking a scientist with background and experience in applied data science research or a related field, and a strong interest in joining a multidisciplinary team dedicated to improving the lives of individuals with breast cancer. This is a full time position. The BRIGHT Run (more…)

Gynecologic Cancer Initiative – Trainee Webinar Series

  The Gynecologic Cancer Initiative is excited to present an 8-week webinar series for graduate students and postdoctoral fellows, providing a fulsome overview of the molecular biology, epidemiology, prevention and treatment of all gynecologic cancers. You’ll learn from experts from BC’s Gynecologic Cancer Initiative who will introduce the basics of (more…)

Updated CanREValue Interim Data Report now available!

As part of a broader engagement strategy, the CanREValue Collaboration has launched a stakeholder consultation process. In late 2019, the CanREValue Collaboration undertook public stakeholder consultation regarding the Interim Data Report developed by the CanREValue Data Working Group. From this consultation, we received 20 constructive submissions from a diverse set (more…)

New Publication: Real-world comparative effectiveness of 2nd line ipilimumab for metastatic melanoma…

ARCC and the CanREValue Collaboration are excited to share our recent study, using Ontario based real-world data to generate real-world evidence on the comparative effectiveness of 2nd line ipilimumab. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada  Dai WF,  Beca JM, Croxford (more…)

CanREValue Interim Methods Report Open for Feedback

The CanREValue Collaboration is pleased to open the feedback consultation period for our Methods Working Group report: CanREValue Collaboration Methods Working Group Progress Report on Real World Survival Data. View the Methods Working Group Report here Feedback Form Stakeholder input is essential to the development of a framework for the incorporation (more…)

ARCC Studentship Deadline Extended – now due April 17th, 2020

Hi Everyone, We have heard your concerns regarding the evolving COVID 19 situation and our approaching deadline, and have made the decision to extend the submission deadline for our Studentship completion until Friday April 17th, 2020.  In addition, we will accept all forms of digital/electronic signatures and/or will accept email (more…)

OICR Recruiting: Biostatistician, Diagnostic Development

Position: Biostatistician Site: MaRS Centre, Toronto Department: Diagnostic Development Reports To: Director, Diagnostic Development Salary: Commensurate with level of experience Hours: 35 hours/week Status: Full-time, Temporary (Two years, with potential for renewal) The Ontario Institute for Cancer Research (OICR) is seeking a talented Biostatistician to join the Diagnostic Development (DD) program, which is (more…)

Cancellation of the 2020 ARCC Conference

Every year, we look forward to connecting with the ARCC Network in person at our annual conference. But, given the growing concerns around COVID-19,  we have made the difficult decision to cancel our in-person conference, scheduled to be held in Saskatoon from May 25th-26th, 2020. We are very disappointed, the (more…)

Call for Content: 2020 Canadian Knowledge Mobilization Forum

The Canadian Knowledge Mobilization Forum was created in 2012 as a professional development forum for practitioners and professionals working in knowledge mobilization across fields and sectors.  It has become recognized as a premiere learning and networking event in Canada – friendly, open, limited in size, and creative. This year the forum (more…)
Canadian Cancer Society Logo

Sr. Manager – Surveillance – Canadian Cancer Society

Click here to view details and Apply Online JOB OVERVIEW: The Senior Manager, Surveillance plays a key role in summarizing cancer statistics and related disease statistics, as well as the interpretation of complex data and scientific research into the development of evidence-based messaging and decisions for the Canadian Cancer Society (more…)